Literature DB >> 23064123

Selected C7-substituted chromone derivatives as monoamine oxidase inhibitors.

Lesetja J Legoabe1, Anél Petzer, Jacobus P Petzer.   

Abstract

A series of C7-substituted chromone (1-benzopyran-4-one) derivatives were synthesized and evaluated as inhibitors of recombinant human monoamine oxidase (MAO) A and B. The chromones are structurally related to a series of C7-functionalized coumarin (1-benzopyran-2-one) derivatives which has been reported to act as potent MAO inhibitors. The results of the current study document that the chromones are highly potent reversible inhibitors of MAO-B with IC(50) values ranging from 0.008 to 0.370 μM. While the chromone derivatives also exhibit affinities for MAO-A, with IC(50) values ranging from 0.495 to 8.03 μM, they are selective for the MAO-B isoform. Structure-activity relationships (SAR) show that 7-benzyloxy substitution of chromone is suitable for MAO-B inhibition with tolerance for a variety of substituents and substitution patterns on the benzyloxy ring. It may be concluded that 7-benzyloxychromones are appropriate lead compounds for the design of reversible and selective MAO-B inhibitors. With the aid of modeling studies, potential binding orientations and interactions of selected chromone derivatives in the MAO-A and -B active sites are examined.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23064123     DOI: 10.1016/j.bioorg.2012.08.003

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  9 in total

1.  Synthesis and evaluation of small molecules bearing a benzyloxy substituent as novel and potent monoamine oxidase inhibitors.

Authors:  Jin-Shuai Lan; Tong Zhang; Yun Liu; Yong Zhang; Jian-Wei Hou; Sai-Sai Xie; Jing Yang; Yue Ding; Zhen-Zhen Cai
Journal:  Medchemcomm       Date:  2017-01-05       Impact factor: 3.597

2.  Chromone and donepezil hybrids as new multipotent cholinesterase and monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease.

Authors:  Xiao-Bing Wang; Fu-Cheng Yin; Ming Huang; Neng Jiang; Jin-Shuai Lan; Ling-Yi Kong
Journal:  RSC Med Chem       Date:  2020-01-07

3.  Synthesis and evaluation of chromone derivatives as inhibitors of monoamine oxidase.

Authors:  Annah N Mpitimpiti; Jacobus P Petzer; Anél Petzer; Johannes H L Jordaan; Anna C U Lourens
Journal:  Mol Divers       Date:  2019-01-21       Impact factor: 2.943

4.  The Benzopyrone Biochanin-A as a reversible, competitive, and selective monoamine oxidase B inhibitor.

Authors:  Najla O Zarmouh; Suresh K Eyunni; Karam F A Soliman
Journal:  BMC Complement Altern Med       Date:  2017-01-10       Impact factor: 3.659

5.  5-Demethoxy-10'-ethoxyexotimarin F, a New Coumarin with MAO-B Inhibitory Potential from Murraya exotica L.

Authors:  Zhen-Ru Xia-Hou; Xiao-Fei Feng; Yu-Fei Mei; Yin-Yan Zhang; Tong Yang; Jie Pan; Jing-Hua Yang; Yun-Song Wang
Journal:  Molecules       Date:  2022-08-03       Impact factor: 4.927

6.  Evaluation of the Isoflavone Genistein as Reversible Human Monoamine Oxidase-A and -B Inhibitor.

Authors:  Najla O Zarmouh; Samia S Messeha; Faisel M Elshami; Karam F A Soliman
Journal:  Evid Based Complement Alternat Med       Date:  2016-03-28       Impact factor: 2.629

7.  Evaluation of the Inhibitory Effects of Bavachinin and Bavachin on Human Monoamine Oxidases A and B.

Authors:  Najla O Zarmouh; Elizabeth A Mazzio; Faisel M Elshami; Samia S Messeha; Suresh V K Eyunni; Karam F A Soliman
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-19       Impact factor: 2.629

8.  Synthesis and Preliminary Biological Evaluation of 1,3,5-Triazine Amino Acid Derivatives to Study Their MAO Inhibitors.

Authors:  Sherine N Khattab; Hosam H Khalil; Adnan A Bekhit; Mohamed Mokbel Abd El-Rahman; Ayman El-Faham; Fernando Albericio
Journal:  Molecules       Date:  2015-09-02       Impact factor: 4.411

9.  Chromenones as Multineurotargeting Inhibitors of Human Enzymes.

Authors:  Carina Lemke; Joscha Christmann; Jiafei Yin; José M Alonso; Estefanía Serrano; Mourad Chioua; Lhassane Ismaili; María Angeles Martínez-Grau; Christopher D Beadle; Tatiana Vetman; Florian M Dato; Ulrike Bartz; Paul W Elsinghorst; Markus Pietsch; Christa E Müller; Isabel Iriepa; Timo Wille; José Marco-Contelles; Michael Gütschow
Journal:  ACS Omega       Date:  2019-12-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.